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Abstract
Despite its clinical relevance, cerebral amyloid angiopathy (CAA) is underdiagnosed worldwide. This retrospective study 
aimed to assess the incidence, etiology, predictors, and outcome of intracerebral hemorrhages (ICHs) in this region, with 
special focus on possible underlying CAA. Database screening of acute cares with intracranial hemorrhage diagnosis within 
01/07/2014–01/07/2018 were conducted analyzing medical records and imaging. Spontaneous ICHs were classified as 
deep (basal ganglionic/thalamic/brainstem) and lobar/cerebellar (i.e., CAA-compatible) ICHs. Probable/definite CAA was 
established using the modified Boston criteria in a subgroup with ‘complete’ radiological/neuropathological work-up. The 
ability of several factors to discriminate between deep and lobar/cerebellar ICHs, between probable/definite CAA and non-
probable CAA cases, and to predict 1-month case fatality was assessed. Of the 213 ICHs identified, 121 were in deep and 92 
in lobar/cerebellar localization. Sub-analysis of 47 lobar/cerebellar ICHs with ‘complete’ work-up identified 16 probable/
definite CAA patients, yielding an estimated 14.7% prevalence of CAA-related ICHs. Chronic hypertension was the most 
prevalent risk factor for all types of ICHs (including CAA-related), with hypertensive excess and younger age being inde-
pendent predictors of deep whereas antiplatelet use of lobar/cerebellar localization. The 1-month case fatality was 33.8%, 
driven predominantly by age and INR > 1.4. Probable/definite CAA diagnosis was independently predicted by age, prior 
intracranial hemorrhage, and antiplatelet use. First in this region and among the few in the literature, this study reports a 
remarkable prevalence of CAA-related ICHs, emphasizing the need for an increased awareness of CAA and its therapeutic 
implications, especially regarding antiplatelets among the elderly.
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Introduction
Stroke is one of the leading causes of death and disabil-
ity globally. After ischemic stroke, intracerebral hemor-
rhage (ICH) is the second most prevalent type, accounting 
for some 10% of all cases (Feigin et al. 2009). The most 
common known risk factors of spontaneous ICHs include 
advanced age, chronic hypertension, cerebral amyloid angi-
opathy (CAA), alcohol and drug abuse, and antithrombotic 
medications (Aguilar and Brott 2011). Recent studies further 
highlight the role of systemic inflammation in determining 
ICH propagation and outcome, and implicate the potential 
protective role of substances with anti-inflammatory proper-
ties (Di Napoli et al. 2014, 2016).
Based on etiological considerations, ICHs are commonly 
classified into deep ICHs (i.e., originating from blood ves-
sels in the basal ganglia, thalamus, or brainstem), predomi-
nantly associated with chronic hypertension/hypertensive 
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arteriopathy, and lobar ICHs, which are most frequently 
related to CAA and, relatively less frequently, to other eti-
ologies such as vascular malformations or tumors (Ikram 
et  al. 2012). The distribution of cerebral microbleeds 
(CMBs) follows a similar anatomical pattern, with chronic 
hypertensive (a.k.a. hyaline) arteriopathy associating pri-
marily with CMBs in deep localizations and CAA typically 
associating with lobar CMBs, sparing the deep structures 
(Greenberg et al. 2009). Of note, cerebellar ICHs and CMBs 
can be attributable to either chronic hypertensive arteriopa-
thy or CAA (Greenberg and Charidimou 2018); therefore, 
their classification in the literature is not unequivocal, some 
authors classifying them as deep (Labovitz et al. 2005) or 
non-lobar (Zia et al. 2007; Samarasekera et al. 2015) while 
others omitting them from analyses (Falcone et al. 2013), 
analyzing them separately (Samarasekera et al. 2012), or 
using alternative classifications (Gregoire et al. 2010).
In CAA, cortical and leptomeningeal small arteries/arte-
rioles and capillaries are degenerated due to the progres-
sive deposition of β-amyloid peptides, associating with both 
CAA-related ischemic alterations (including microinfarc-
tions and leukoaraiosis) and different types of hemorrhages 
[including CMBs and ICHs in lobar (and cerebellar) locali-
zation, and cortical superficial siderosis (CSS, a.k.a. con-
vexity subarachnoid hemmorhage (SAH))] (Yamada 2015).
Clinical manifestations of CAA can be various, ranging 
from asymptomatic stage to fatal ICHs. Typically, CAA-
related ICHs are recurrent and cause various neurological 
deficits (depending on localization), headache, and epilep-
tic seizures with or without loss of consciousness (Yamada 
2015). Patients usually develop slowly progressive cogni-
tive impairment due to multiple CMBs and microinfarctions 
(i.e., vascular neurocognitive disorder or mixed-type neuro-
cognitive disorder, in the presence of concomitant Alzhei-
mer’s disease (AD) pathology). In addition, CAA patients 
frequently experience transient ischemic attack (TIA)-like 
events, a.k.a. transient focal neurological episodes (TFNEs) 
or ‘amlyoid spells’; these events are, however, presumed to 
be due to focal epileptic activity secondary to CSS and not 
thrombotic in origin (Yamada 2015).
Magnetic resonance imaging (MRI) sequences sensitive 
to susceptibility artifacts generated by hemosiderin depos-
its of previous micro- and macrobleeds, such as gradient 
echo (GRE), susceptibility-weighted imaging (SWI), or T2* 
sequences, in addition to a set of clinical characteristics, 
make it possible to establish a probabilistic diagnosis of 
CAA in vivo with high diagnostic accuracy (Greenberg and 
Charidimou 2018). The original Boston criteria was modi-
fied in 2010 recognizing CSS as part of CAA-related altera-
tions (Linn et al. 2010). This Modified Boston criteria (with 
increased sensitivity and retained specificity) enables estab-
lishing the diagnosis of possible CAA and probable CAA 
without histological confirmation (i.e., biopsy specimen 
or post mortem tissue) in patients above 55 years, with the 
presence of a single hemorrhagic alteration (ICH, CMB, or 
CSS) in lobar localization without other cause allowing the 
diagnosis of possible CAA, and > 1 of such hemorrhagic 
alterations without other cause meeting the diagnosis of 
probable CAA (Linn et al. 2010). While deep (basal gan-
glionic, thalamic, and brainstem) hemorrhagic alterations 
preclude the diagnosis of both possible and probable CAA, 
cerebellar bleeds are allowed, albeit not counted for the 
diagnosis (Greenberg and Charidimou 2018). Definite CAA 
diagnosis can be established only via full post mortem his-
tological investigation.
CAA is by no means infrequent. Affecting some 5% of the 
population over 65 years of age (Biffi and Greenberg 2011), 
its prevalence is comparable to that of AD (Lobo et al. 2000) 
[with which it shows some 70–80% overlap (Jellinger 2002; 
Brenowitz et al. 2015)] and atrial fibrillation (AF) (Majeed 
et al. 2001). Though curative therapy is lacking, the clinical 
relevance of the diagnosis is high. Indeed, the use of anti-
coagulants is contraindicated in CAA according to current 
guidelines due to a 7–tenfold increase in the risk of ICH 
(Kernan et al. 2014; Heidbuchel et al. 2015). The use of anti-
platelet therapy should also be carefully considered in CAA, 
due to an up to fourfold increase in the risk of recurrent ICH 
in general population after lobar ICH (Biffi et al. 2010) and 
a twofold prevalence of lobar CMBs in patients suffering 
ICH while on antiplatelet therapy (Gregoire et al. 2010). 
Though prior ICH has always been an absolute contraindi-
cation for systemic thrombolysis in acute ischemic stroke, 
a > 10 CMB number per se has recently been introduced 
as a contraindication due to uncertain benefit (Powers et al. 
2018). Despite the high prevalence and relevance among the 
elderly, the establishment of a clinical diagnosis of CAA to 
our experience has been sporadic. Based on the discrepancy 
between the expected frequency of CAA among the elderly 
and the experienced occurrence of CAA diagnosis in the 
routine clinical practice, our aim was to asses the frequency 
of the different types of spontaneous ICHs observed in our 
stroke center with special focus on estimating the underlying 
prevalence of CAA, by means of the retrospective re-evalu-
ation of written and imaging documentation. Emphasis was 
given on the analysis of the predictive value of putative risk 
factors for ICH location, probable/definite CAA diagnosis, 
and fatal outcome.
Materials, patients, and methods
Via screening the electronic database, patients who received 
acute in-patient care in our center between 01/07/2014 and 
01/07/2018 with any of the intracranial hemorrhage-related 
International Classification of Diseases (ICD) diagnosis codes 
were identified. Reviewing the imaging scans and medical 
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages:…
1 3
records, spontaneous ICHs were separated from intracranial 
hemorrhages with traumatic etiology, cases with SAH, pri-
mary intraventricular hemorrhage, and hemorrhagic transfor-
mation of ischemic stroke, and from cases with inadequate 
coding. Spontaneous ICHs were further classified according to 
hematoma localization as deep ICHs (basal ganglia, thalamus, 
or brainstem) and lobar/cerebellar ICHs (regions compatible 
with the diagnosis of probable CAA, enabling the estimation 
of the prevelance of underlying CAA).
The prevalence of different etiologies behind lobar/cer-
ebellar ICHs was assessed in a subpopulation who under-
went ‘complete’ clinical work-up, defined as being subjected 
to computed tomography angiography (CTA) or magnetic 
resonance angiography (MRA) as well as MRI-SWI (if struc-
tural etiology was not identified by angiography) and/or post 
mortem neuropathological work-up. Definite CAA, probable 
CAA, and possible CAA diagnoses were retrospectively estab-
lished or revised as per the Modified Boston criteria (Linn 
et al. 2010). An ICH was considered CAA-related if it met the 
criteria for probable and/or definite CAA.
Clinical data collected about the patients included their age 
at the time of ICH, sex, history of intracranial vascular events 
(including TIA, clinical episode of ischemic or hemorrhagic 
stroke), family history of any stroke, prior episodes of loss 
of consciousness, chronic hypertension, hypertensive excess 
at presentation (defined as ≥ 180 mmHg systolic blood pres-
sure), current use of antiplatelet and/or anticoagulant drugs, 
as well as the international normalized ratio (INR) values on 
admission for ICH. Case fatality (lethality) was defined as fatal 
outcome within 1 month secondary to the ICH event in the 
absence of evidence for unrelated cause of death (e.g., cardiac 
arrest).
For statistical analysis, the SPSS 20.0 software (IBM Corp., 
Armonk, New York, USA; RRID:SCR_002865) was used. For 
comparative assessment of continuous variables, parametric 
(Student t) or non-parametric (Mann–Whitney U) tests were 
used after normality analysis with the Shapiro–Wilk test. For 
comparative analysis of discrete variables, cross-tabulation 
analysis was used by the  Chi2 test, applying Fisher’s exact 
values when appropriate. Backward conditional multivariate 
binary logistic regression analyses were used to assess the 
effect of predictors found to be significant in the univariate 
comparative analyses. The binary outcomes were deep ICHs 
vs. lobar/cerebellar ICHs, case fatality at 1 month vs. alive at 
1 month, and probable/definite CAA vs. non-probable CAA 
(including all deep ICHs and the subgroup of lobar/cerebellar 
ICH with ‘complete’ clinical work-up not meeting the crite-
ria for probable/definite CAA). The level of significance was 
p < 0.05. Data within the text are presented as mean ± standard 
error of the mean (SEM) or median [interquartile range] in 
the cases of normal or non-normal distribution, respectively.
Results
Revision of diagnoses, estimation of CAA‑related 
ICH prevalence
A total of 324 patients having received any intracranial hem-
orrhage-related ICD codes as leading diagnosis in the given 
period were identified. After exclusions, 213 spontaneous 
ICHs were identified (Fig. 1). Among spontaneous ICHs, 
121 deep ICHs [110 (51.6%) localized to the basal ganglia/
thalamus and 11 (5.2%) to the brainstem) and 92 lobar/cer-
ebellar ICHs (85 (39.9%) localized to any cerebral lobe and 
7 (3.3%) to the cerebellum] were detected (Fig. 2a).
Out of lobar/cerebellar ICHs, 47 had ‘complete’ clini-
cal work-up, of whom 2 proved to be definite CAA post 
mortem (Online Resource 1) and 14 were consistent with 
the diagnosis of probable CAA clinically (Fig. 3; one of 
them also became definite post mortem), rendering (16/47) 
34.0% of all ‘completely’ worked-up lobar/cerebellar ICHs 
and (considering this rate as representative for all lobar/cer-
ebellar ICHs) an estimated 14.7% of all spontaneous ICHs 
to be CAA-related. CMBs were present in 92.9% of prob-
able CAA cases, with 42.9% having > 10 CMBs, whereas 
CSS was present in 78.6%, with 57.1% of probable CAA 
cases having diffuse CSS. In addition, ten patients met the 
criteria for possible CAA, and another five patients would 
have also met the criteria for probable (1) and possible CAA 
(4) except for their age being under 55. In 12 cases (25.5%), 
structural (i.e., secondary) etiologies such as arteriovenous 
malformation, ruptured aneurysm, sinus thrombosis, dural 
arteriovenous fistula or metastatic tumor were detected, 
whereas 4 cases (8.5%) were consistent with hypertensive 
arteriopathy (Fig. 2b). Out of the 14 probable CAA cases 
Fig. 1  Flow diagram of the process of identifying spontaneous intrac-
erebral hemorrhages (ICHs)
 B. Fakan et al.
1 3
identified, originally only 4 had received CAA at least as 
suspected diagnosis (28.6%).
Analysis of possible discriminators of ICH subgroups
The median age of the 213 patients with spontaneous ICH 
was 69.1 [60.3–79.0] years, with the lobar/cerebellar ICH 
group being significantly older compared to deep ICHs (74.5 
[65.9–82.0] vs. 64.7 [57.9–76.6] years; p < 0.001; Table 1).
The distribution of sex was significantly different between 
deep and lobar/cerebellar ICH groups (p = 0.029), with a 
remarkable male preponderance in deep ICHs (66.9%) and 
a close to even ratio in lobar/cerebellar ICHs.
The frequency of prior episode(s) of TIA (TFNE), 
ischemic stroke, intracranial hemorrhage, and loss of con-
sciousness in all ICHs were 10.5%, 12.4%, 8.1%, and 8.1%, 
respectively, being comparable between deep and lobar/cer-
ebellar ICH groups.
The family history for either ischemic or hemorrhagic 
stroke (specification was not possible) was positive in 32.5%, 
with no between-group difference.
A total of 16.7% of ICH cases were on anticoagulant 
therapy at presentation, 74.3% because of AF. Three-quar-
ter (77.1%) of anticoagulated patients were on a vitamin 
K antagonist [VKA; warfarin (4/27) or acenocoumarol 
(23/27)], 88.9% of whom had an INR > 1.4 at presenta-
tion. Two patients were on rivaroxaban, one on apixa-
ban, together making up 8.6% of anticoagulated patients, 
while other direct oral anticoagulants (DOACs) were not 
represented. In five patients (14.3%), different doses of 
low-molecular-weight heparin (LMWH) were used. The 
frequency of anticoagulant use at presentation was com-
parable between ICHs in deep and lobar/cerebellar locali-
zations. Notably, out of the seven lobar/cerebellar ICH 
patients with a positive history of intracranial hemorrhage, 
three were on therapeutic anticoagulation, and two of them 
were on antiplatelet treatment as well. Antiplatelet use 
was present in 32.2%, with a significant preponderance in 
lobar/cerebellar (43.3%) compared to deep ICHs (23.7%; 
p = 0.003). Altogether 7.7% of ICH patients were on com-
bined antithrombotic regimen (on both anticoagulant and 
antiplatelet therapy), the significant majority (75.0%) suf-
fering a lobar/cerebellar ICH (p = 0.016).
A total of 191 ICH patients were known for chronic 
hypertension (89.7%), which was the most prevalent risk 
factor for both deep and lobar/cerebellar ICHs, with no 
significant between-group difference. On the other hand, 
61.5% of ICH patients experienced hypertensive excess 
(systolic blood pressure > 180 mmHg) at presentation, in 
a significantly higher rate in the deep compared to the 
lobar/cerebellar ICH group (71.2% vs. 48.9%, respectively, 
p = 0.001).
Analyzing the risk factors with significant between-
group difference (age, sex, antiplatelet use, combined 
antithrombotic treatment, and hypertensive excess at pres-
entation) in a multivariate binary logistic regression model 
revealed advanced age [p = 0.014; odds ratio (OR) = 1.03] 
and antiplatelet use (p = 0.043; OR = 1.96) to be statis-
tically significant independent predictors of a lobar/cer-
ebellar ICH, and hypertensive excess to be a strong sig-
nificant independent predictor of a deep ICH (p = 0.002; 
OR = 0.39).
Fig. 2  a Localization of spontaneous intracerebral hemorrhages (ICHs). b The distribution of underlying etiologies within lobar/cerebellar ICHs
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Case fatality
The 1-month case fatality of ICH patients was 33.8%, with 
no significant difference between deep and lobar/cerebellar 
ICH groups (Table 1). Significant determinants of 1-month 
case fatality in ICHs as a whole were age, prior TIA, cur-
rent anticoagulant use, and INR > 1.4 in univariate compari-
sons, with only advanced age (p = 0.003; OR = 1.04) and 
Fig. 3  Representative axial MRI-SWI images of probable CAA 
patients at different parts of the spectrum. a Diffuse CSS with multi-
ple lobar CMBs and ICHs of different ages. b Diffuse (but less exten-
sive) CSS with a recurrent lobar ICH and a single CMB. c No CSS 
but multiple lobar CMBs accompanying a recent lobar ICH. The deep 
structures (i.e., basal ganglia, thalamus, and brainstem) are consist-
ently devoid of hemorrhagic pathology. CAA cerebral amyloid angi-
opathy, CMB cerebral microbleed, CSS cortical superficial siderosis, 
ICH intracerebral hemorrhage, MRI magnetic resonance imaging, 
SWI susceptibility-weighted imaging
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INR > 1.4 (p = 0.035; OR = 2.51) proven to be independent 
predictors of case fatality in multivariate analysis (Online 
Resource 2).
Analysis of factors to predict CAA 
The probable/definite CAA subgroup had the highest mean 
age at ICH presentation (75.9 ± 2.3 years), significantly 
higher compared to non-probable CAA patients (65.6 ± 1.1 
years; p = 0.002). This was associated with a significant 
female predominance in probable/definite CAA (62.5%) as 
opposed to the male predominance (64.5%) in the compara-
tor (p = 0.035).
Some 31.3% of probable/definite CAA cases had prior 
clinical event(s) of intracranial hemorrhage and exactly the 
same rate had prior TIA/TFNE, significantly higher than in 
the non-probable CAA group [6.8% (p = 0.008) and 7.4% 
(p = 0.010), respectively].
The ratio of patients on antiplatelet therapy (56.3%) 
within the definite/probable CAA subgroup was remarka-
bly higher compared to non-probable CAA patients [25.2% 
(p = 0.009)].
Other factors and case fatality were not significantly dif-
ferent in the comparative analyses; of note, chronic hyper-
tension was invariably prominent (Table 2).
Multivariate analysis of factors significant in the uni-
variate comparative analyses revealed older age (p = 0.012; 
OR = 1.08), prior intracranial hemorrhage (p = 0.005; 
OR = 8.53), and antiplatelet use (p = 0.042; OR = 3.45) as 
independent significant predictors of definite/probable CAA 
diagnosis.
Discussion
Aiming to assess the predictors and outcome of spontaneous 
ICHs of different localization with particular focus on the 
prevalence of underlying CAA, this study identified hyper-
tensive excess and younger age as independent predictors of 
deep whereas antiplatelet use of lobar/cerebellar localiza-
tion, advanced age and INR > 1.4 as indepenent predictors 
of 1-month case fatality, and advanced age, prior intracranial 
hemorrhage, and antiplatelet use as independent predictors 
of probable/definite CAA diagnosis, in addition to an esti-
mated prevelance of CAA-related ICHs comparable to prior 
publications.
The timely identification of patients with probable CAA 
is imperative, as it is associated with serious therapeu-
tic consequences, especially regarding the avoidance of 
antithrombotic/thrombolytic medications, with increasing 
literature demonstrating a higher risk of harm compared 
to benefit (Yamada 2015). Despite these, CAA is consid-
ered to be underdiagnosed worldwide, its epidemiology 
is largely based on neuropathological case series, and the 
Table 1  Discriminators of spontaneous ICHs with regard to localization
MW/Chi2, Mann–Whitney test (for Age at event) or  Chi2 test (for other variables), CI confidence interval, ICH intracerebral hemorrhage, INR 
international normalized ratio, OR odds ratio, TIA transient ischemic attack, TFNE transient focal neurological episode, y year (median [inter-
quartile range])
a Indicates significant predictors in the multivariate analyses
Bold font indicates variables with significant difference in univariate analyses
Lobar/cerebellar Deep MW/Chi2 multivariate logistic regression
ICH ICH p p OR (95% CI)
Patient number 92 121 – –
Age at eventa (y) 74.5 [65.9–82.0] 64.7 [57.9–76.6]  < 0.001 0.014 1.03 (1.01–1.06)
Sex (male/female) (%) 52.2 66.9 0.029  > 0.05 –
Prior ischemic stroke (%) 12.0 12.7  > 0.05 – –
Prior intracranial hemorrhage (%) 7.7 8.5  > 0.05 – –
Prior TIA (TFNE) (%) 14.1 7.6  > 0.05 – –
Prior loss of consciousness (%) 9.8 6.8  > 0.05 – –
Family history for any stroke (%) 37.5 28.8  > 0.05 – –
Anticoagulant use (%) 20.9 13.4  > 0.05 – –
INR > 1.4 (%) 18.4 11.4  > 0.05 – –
Antiplatelet usea (%) 43.3 23.7 0.003 0.043 1.96 (1.02–3.75)
Combined antithrombotic use (%) 13.3 3.4 0.016  > 0.05 –
Hypertensive excessa (%) 48.9 71.2 0.001 0.002 0.39 (0.21–0.71)
Chronic hypertension (%) 88.0 90.9  > 0.05 – –
Case fatality (1-month) (%) 34.8 33.1  > 0.05 – –
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prevalence of CAA among ICH patients (i.e., CAA-related 
ICH) with/without associated potential risk factors have 
only been addressed by a few studies on clinical grounds 
(Online Resource 3) (Meretoja et al. 2012; Yeh et al. 2014; 
Roh et al. 2018; Jamieson et al. 2012; Palm et al. 2013). 
Consequently, our aim was to revise all spontaneous ICH 
cases in our center in a 4-year period, with special focus on 
identifying patients with probable/definite CAA, and analyz-
ing associated risk factors and fatal outcome.
The 213 ICH cases detected represent an incidence of 
approximately 13.3/100,000 persons/year, resembling the 
12–15/100,000 persons/year reported in the U.S. (Aguilar 
and Brott 2011). In our study, 51.6% of spontaneous ICHs 
originated in the basal ganglia/thalamus, 3.3% in the cer-
ebellum, 5.2% in the brainstem, and 39.9% were of lobar 
localization. According to international data reporting 
35–70%, 5–10%, 5–10%, and 15–30%, respectively (Agui-
lar and Brott 2011), this suggests a relative overrepresenta-
tion of lobar ICHs compared to expectations, highlighting 
the relevance and necessity of an increased awareness of 
CAA in this population. This ratio is similar to Swedish 
and US findings with 43.2% and 40.5% rates of lobar ICHs, 
respectively (Zia et al. 2007; Broderick et al. 1993). The 
analysis of risk factors confirmed ICH as the disease of the 
elderly [the median 69.1 years being consistent with pre-
vious reports (O’Donnell et al. 2010)]. In particular, older 
age proved to be an independent predictor of lobar/cerebel-
lar (i.e., CAA-compatible) ICH localization, resembling 
findings for lobar ICHs (Labovitz et al. 2005; Matsukawa 
et al. 2012; Weimar et al. 2011). Hypertension was by far 
the most common coexistent factor (~ 90%) irrespective 
of ICH localization. Identifying hypertension as primary 
risk factor for ICHs is consistent with international meta-
analyses (Ikram et al. 2012; O’Donnell et al. 2010; Ariesen 
et al. 2003); however, its prevalence was higher than in 
many individual studies (Zia et al. 2007; Yeh et al. 2014; 
Broderick et al. 1993), albeit similar to some reports from 
Europe (Smajlovic et al. 2008; Safatli et al. 2016). Despite 
the concept that chronic hypertension would associate more 
with deep ICHs, our results emphasize that it is essentially 
present in any subtypes of ICHs [in line with some prior 
observations (Broderick et al. 1993)] and only an extreme 
hypertension around the event demonstrated to be a signifi-
cant (in fact the strongest) predictor of deep ICHs. Male 
sex, a factor frequently reported as a risk for ICH (Labovitz 
et al. 2005; Ariesen et al. 2003; van Asch et al. 2010), was 
also slightly overrepresented in the pooled cohort (60.6%), 
driven, however, entirely by deep ICHs (66.9%), with the 
sex rate of lobar/cerebellar ICHs being ~ 50%, recapitulat-
ing prior observations (Labovitz et al. 2005; Zia et al. 2007; 
Yeh et al. 2014). The use of antithrombotics were frequent 
(41.1%), with antiplatelet use proven to be an independent 
predictor of lobar/cerebellar ICH localization. The results 
were practically identical when using the traditional lobar 
vs. non-lobar comparison (Online Resource 4).
Table 2  Discriminators of spontaneous ICHs with regard to probable/definite CAA diagnosis
St/Chi2, Student t test (for Age at event) or  Chi2 test (for other variables); CI confidence interval, ICH intracerebral hemorrhage, INR interna-
tional normalized ratio, OR odds ratio, TIA transient ischemic attack, TFNE transient focal neurological episode, y year (mean ± SEM)
a Indicates significant predictors in multivariate analyses
Bold font: indicates variables with significant difference in univariate analyses
Probable/definite Non-probable St/Chi2 multivariate logistic regression
CAA CAA p p OR (95% CI)
Patient number 16 152 – –
Age at eventa (y) 75.9 ± 2.3 65.6 ± 1.1 0.002 0.012 1.08 (1.02–1.15)
Sex (male/female) (%) 37.5 64.5 0.035  > 0.05 –
Prior ischemic stroke (%) 18.8 10.7  > 0.05 – –
Prior intracranial hemorrhagea (%) 31.3 6.8 0.008 0.005 8.53 (1.94–37.58)
Prior TIA (TFNE) (%) 31.3 7.4 0.010  > 0.05 –
Prior loss of consciousness (%) 18.8 6.0  > 0.05 – –
Family history for any stroke 42.9 29.1  > 0.05 – –
Anticoagulant use (%) 18.8 12.8  > 0.05 – –
INR > 1.4 (%) 20.0 10.4  > 0.05 – –
Antiplatelet usea (%) 56.3 25.2 0.009 0.042 3.45 (1.05–11.38)
Combined antithrombotic use (%) 6.4 4.1  > 0.05 – –
Hypertensive excess (%) 46.7 64.2  > 0.05 – –
Chronic hypertension (%) 93.8 88.8  > 0.05 – –
Case fatality (1-month) (%) 31.3 28.9  > 0.05 – –
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The 1-month case fatality of all ICHs was 33.8%, with 
no significant effect of localization. This rate is consistent 
with a previous report from this region (Ovary et al. 2004) 
and similar to reports from the US (Labovitz et al. 2005), 
being somewhat favorable compared to international 
median of 40.4% in a recent meta-analysis (van Asch et al. 
2010). The identification of age as an independent deci-
sive factor recapitulates this meta-study (van Asch et al. 
2010). Though resembling findings of SMASH-U studies 
for medication-related ICHs (Meretoja et al. 2012; Yeh 
et al. 2014), the independent prognostic value of admis-
sion INR > 1.4 (but not of anticoagulant use per se in 
the multivariate analysis) is a novelty [to our knowledge 
reported previously only in primary lobar ICHs (Falcone 
et al. 2013)], giving an additional context to the risk posed 
by anticoagulants, particularly VKAs.
The analysis of potential clinical predictors of CAA-
related ICHs revealed older age (~ 8% increase in risk per 
year) and prior intracranial hemorrhage (~ 8.5-fold risk) as 
independent significant predictors of probable/definite CAA 
diagnosis, which is consistent with the notion that CAA is 
the disease of the elderly (Yamada 2015) and CAA-related 
ICHs are often recurrent (Biffi and Greenberg 2011). These, 
together with the female predominance in probable/definite 
CAA (though proven to be not independent of age) reca-
pitulate key observations of a recent study from the US 
comparing their probable/definite CAA-related ICH group 
with hypertension-related ICHs (as per SMASH-U) (Roh 
et al. 2018), and concord with autopsy studies demonstrating 
female predominance in CAA-related ICHs (Attems et al. 
2008; Hirohata et al. 2010).
Highlighting its primary role in ICH development irre-
spective of etiology, our data indicates that pre-existing 
hypertension is invariably associated with definite/probable 
CAA diagnosis (93.8%), with the prevalence of hypertensive 
excess at presentation (46.7%) not being significantly differ-
ent from the comparator group either.
Though significant only at the univariate level, a remark-
ably high rate of definite/probable CAA patients (31.3%) 
had experienced prior ‘TIA’ compared to non-probable 
CAA (7.4%), presumably representing ‘amyloid spells’, sug-
gested to be of epileptic origin. Interpreting these events as 
‘ischemic’ necessarily adds to the inherited risk of ICH in 
CAA, due to the consequent initiation of antiplatelet therapy. 
Indeed, antiplatelet and anticoagulant drugs are considered a 
risk for ICH in CAA. Our study concords with this, reveal-
ing 68.8% of ICH patients with definite/probable CAA to be 
under at least one type of antithrombotic medication, with 
the multivariate analysis identifying antiplatelet (but not 
anticoagulant) use as an independent predictor of probable/
definite CAA diagnosis. The 3.3-times higher prevalence 
of probable/definite CAA diagnosis in antiplatelet users 
vs. non-users resembles the twofold prevalence of lobar 
microbleeds in antiplatelet user ICH patients in a previous 
study (Gregoire et al. 2010).
Underlying the relevance of missed diagnoses, a patient 
with fatal CAA-related ICH was on combined antithrom-
botic therapy despite a prior lobar ICH 1 year before the 
index ICH, having an SWI scan at first ICH already con-
sistent with probable CAA, retrospectively.
Our study has a number of limitations, including its ret-
rospective nature, resulting in a certain amount of random 
missing values regarding some clinical factors analyzed, 
decreasing their statistical power. Strengths include the 
relatively large subject number, to our knowledge being 
among the largest studies reporting multivariate binary 
analysis of clinical discriminators of ICH localization, 
overtaken by a study from Japan (Matsukawa et al. 2012) 
and Germany (Weimar et al. 2011). Additional strength is 
the unprecedented rigor that probable and possible CAA 
diagnoses were established in (and thus CAA-related ICH 
prevalence estimated based on) a subgroup with ‘com-
plete’ work-up including MRI-SWI and angiography (not 
allowing CT-only), increasing diagnostic sensitivity and 
specificity.
Conclusion
This study provides an in-depth retrospective analysis of 
spontaneous ICHs, with particular focus on the prevalence 
and clinical predictors of CAA-related ICH, first in a coun-
try from this region, and among the few reports previously 
published in the literature. We conclude that CAA-related 
ICHs are at least as frequent (14.7%) in our population 
as reported internationally (5–20%) (Biffi and Greenberg 
2011). Notably, the remarkably low rate of clinically and 
radiologically established probable CAA diagnosis puts 
a significant percentage of the population, especially the 
elderly under antiplatelet therapy (as demonstrated), at a 
high risk of possibly lethal ICHs. This highlights the need 
for an increased awareness of CAA by both neurologists 
and radiologists.
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